Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
30 studies found for:    " December 04, 2013":" January 03, 2014"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Show Display Options
RSS Create an RSS feed from your search for:
" December 04, 2013":" January 03, 2014"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Need help? See RSS Feeds
Choose a feed type:
Show studies first received on any dateShow studies that were first received in the last 14 days
Show studies last updated date on any dateShow studies that were added or modified in the last 14 days
Rank Status Study
1 Unknown  Safety of and Immune Response to Vaccination With 2 Experimental HIV Vaccines in Healthy Adults
Condition: HIV Infection
Interventions: Biological: ALVAC-HIV;   Biological: AIDSVAX B/E;   Biological: Placebo for ALVAC-HIV;   Biological: Placebo for AIDSVAX B/E;   Biological: Hepatitis B vaccine;   Biological: Tetanus toxoid vaccine;   Biological: Placebo for hepatitis B vaccine;   Biological: Placebo for tetanus vaccine
2 Active, not recruiting Third Line Antiretroviral Treatment Optimization in Sub-Saharan Africa
Condition: HIV Infection
Interventions: Behavioral: adherence reinforcement;   Drug: Antiretroviral Therapy Darunavir/r + Raltegravir + 2 NRTIs (as chosen by the investigators)
3 Completed The Use of Peer Referral Incentives to Increase Demand for Voluntary Medical Male Circumcision in Zambia
Condition: HIV Infection
Intervention: Other: Peer‐referral incentive program to increase VMMC uptake
4 Completed Safety and Immune Response of BMS-936559 in HIV-Infected People Taking Combination Antiretroviral Therapy
Condition: HIV Infections
Interventions: Drug: BMS-936559;   Drug: Placebo for BMS-936559
5 Recruiting Pharmacokinetics, Safety, and Efficacy of Cobicistat-boosted Atazanavir or Cobicistat-boosted Darunavir in HIV-1 Infected, Treatment-Experienced, Virologically Suppressed Pediatric Subjects
Conditions: Acquired Immune Deficiency Syndrome (AIDS);   HIV Infections
Interventions: Drug: ATV;   Drug: DRV;   Drug: Cobicistat;   Drug: BR
6 Unknown  Systems Analysis and Improvement to Optimize pMTCT
Condition: HIV
Intervention: Other: pMTCT systems analysis and improvement
7 Completed Immunogenicity and Safety of 4 Prime-boost Combinations of HIV Vaccine Candidates in Healthy Volunteers
Condition: HIV Infection
Interventions: Biological: LIPO-5;   Biological: MVA HIV-B (MVATG17401);   Biological: GTU®-MultiHIV B: 0.5 mL IM via Biojector® 2000 and 0.5mL IntraDermic, 3 shots
8 Active, not recruiting Niacin on Immune Activation : a Proof-of-concept Study
Condition: HIV
Intervention: Drug: Niacin
9 Unknown  Promoting Uptake and Retention of Option B+ in Malawi
Condition: HIV
Interventions: Other: Community based peer support;   Other: Facility-based Peer Support
10 Active, not recruiting Comprehensive Triaged HIV Prevention in Tanzania
Condition: HIV
Intervention: Behavioral: Comprehensive Triaged HIV Prevention (CTHP)
11 No longer available Compassionate Use of Ibalizumab for the Treatment of HIV Infection
Condition: Human Immunodeficiency Virus (HIV)
Interventions: Drug: Dolutegravir Sodium Monohydrate;   Drug: Ibalizumab
12 Unknown  Assessment of Group Peer Support to Children With HIV in Vietnam
Condition: Human Immunodeficiency Virus (HIV)
Intervention: Behavioral: Enhanced Treatment Support (ETS)
13 Completed Strategies to Increase HIV Testing, Linkages to Care, and Male Circumcision in Africa
Condition: HIV
Interventions: Other: POC CD4 Testing;   Other: CD4 Referral;   Behavioral: Lay Counselor Follow-up;   Behavioral: Clinic Accompaniment;   Behavioral: Clinic Referral;   Behavioral: SMS Reminder;   Behavioral: Circumcision Promotion;   Other: POC VL;   Other: Laboratory based VL assay
14 Completed Enhanced HIV Prevention in Couples: Feasibility Study #3
Conditions: Human Immunodeficiency Virus (HIV);   Acquired Immune Deficiency Syndrome (AIDS)
Intervention: Other: HIV Self-testing with Standard Counseling and Testing (SCT) Confirmation
15 Completed A Phase 1, Open Label, Dose-escalation Study of the Safety, Pharmacokinetics and Antiretroviral Activity of 3BNC117
Conditions: Healthy;   HIV
Interventions: Biological: 1 mg/kg, single dose IV administration of 3BNC117;   Biological: 3 mg/kg, single dose IV administration of 3BNC117;   Biological: 10 mg/kg, single dose IV administration of 3BNC117;   Biological: 30 mg/kg, single dose IV administration of 3BNC117;   Biological: 10 mg/kg, two doses IV of 3BNC117;   Biological: 30 mg/kg, two doses IV of 3BNC117
16 Active, not recruiting A Pilot Study to Examine Efficacy of Peer Mentoring in Promoting Medication Adherence Among People Living With HIV/AIDS
Condition: HIV
Intervention: Behavioral: Peer Mentoring
17 Recruiting Quantifying Drug Adherence and Drug Exposure to Antiretroviral Therapy
Condition: HIV/AIDS
Intervention:
18 Active, not recruiting Artefill for the Treatment of HIV-associated Facial Lipoatrophy
Condition: HIV-facial Lipoatrophy
Intervention: Drug: Artefill dermal filler
19 Completed
Has Results
Efficacy Study of Different Laboratory Management Strategies and Drug Regimens in HIV-infected Children in Africa
Condition: Human Immunodeficiency Virus
Interventions: Other: Clinically Driven Monitoring (CDM);   Other: Laboratory plus Clinical Monitoring (LCM);   Drug: Arm A: ABC+3TC+NNRTI;   Drug: Arm B: ZDV+ABC+3TC+NNRTI->ABC+3TC+NNRTI maintenance;   Drug: Arm C: ZDV+ABC+3TC+NNRTI->ZDV+ABC+3TC maintenance;   Drug: Once-daily ABC+3TC;   Drug: Twice-daily ABC+3TC;   Drug: Continued cotrimoxazole prophylaxis;   Other: Stopped cotrimoxazole prophylaxis
20 Unknown  Scale-up of an Internet-Delivered Study for HIV+ Men
Condition: HIV
Intervention: Behavioral: Video treatments

   Previous Page Studies Shown (1-20) Next Page (21-30) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.